Lord's Mark

What Lord's Mark does

Lord's Mark Industries Ltd. is an Indian privately held diversified conglomerate headquartered in Mumbai, originally founded in 1998 with operations spanning the Paper, LED-Solar, and Diagnostics and Medtech sectors. The company has materially repositioned its growth agenda around healthcare technology since late 2025, with a stated focus on indigenous AI-powered medical devices and platforms under a 'Make in India' positioning. It operates a state-of-the-art manufacturing plant in Dadra & Nagar Haveli and has built an engineering and R&D footprint through the 85% acquisition of Bengaluru-based Renalyx Health Systems in November 2025.

The core healthcare offering is an integrated AI-powered renal care ecosystem composed of three interconnected components: the Lord's Renal Renalyx Machine (an indigenous AI-enabled hemodialysis system), the RenalOS AI clinical intelligence platform (providing real-time monitoring, predictive alerts, anomaly detection, and clinical decision support), and Aureoon (a Dialysis-as-a-Service managed operations model that allows hospitals to deploy fully managed centres with zero capital investment). The company's diagnostics portfolio includes the LordsMed HIV 1&2 Self Test (a Class D in-vitro diagnostic cleared by India's Central Licensing Authority, placing the company among only three Indian and nine global holders of this approval) and an AI-powered, radiation-free breast cancer detection wearable being co-developed with CMET. It also markets 153 US FDA-listed orthosurgical products manufactured at its Indian facility.

Lord's Mark generates revenue through a mix of hardware sales (dialysis equipment, diagnostic kits, orthosurgical products), managed services (per-session fees under the Aureoon model), and international exports. Its go-to-market combines enterprise field sales to hospitals for dialysis systems, direct-to-consumer distribution of HIV self-test kits, and export distribution into regulated markets (United States, European Union, Africa, Latin America, and the Middle East). The company relies primarily on public relations, earned media around regulatory milestones, and healthcare industry events rather than paid digital marketing, and it has signed flagship deployments such as the Shakti Super Speciality Hospital in Ahmedabad as the first commercial site for the integrated renal ecosystem.

Name

Lord's Mark

Legal name

Lord's Mark Industries Ltd.

Website

https://lordsmark.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

Lord's Mark Industries is an Indian diversified conglomerate pivoting into healthcare technology, building an integrated AI-powered renal care ecosystem (Renalyx machines, RenalOS AI platform, Aureoon managed services), HIV self-test diagnostics, US FDA-listed orthosurgical products, and an AI breast cancer detection wearable for hospitals and international export markets.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Kidney Dialysis Centers (621492), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Hemodialysis Machines & Systems (HLAHAKAA)

akta.pro secondary industries

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• Hemodialysis machines
• Medical diagnostic devices
• Renal care services
• Orthosurgical products
• AI healthcare technology

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Dialysis Equipment and Consumables Sales: Sale of Lord's Renal Renalyx Machine and related dialysis consumables to hospitals and healthcare facilities
2. Dialysis-as-a-Service Managed Operations: Managed dialysis centre operations where Lord's Mark provides complete infrastructure, AI systems, and operational support to hospital partners with zero capital required from them. Revenue generated through service fees per dialysis session
3. Diagnostic Kit Exports: Export of LordsMed HIV 1&2 Self Test kits to Africa, Europe, and Latin America markets starting June 2026
4. Orthosurgical Products: Sale of 153 US FDA-listed orthosurgical products to regulated international markets including US, Latin America, and Middle East

Go-to-market motion4 records

Distribution channels3 records

Marketing channels3 records

Core offering

Lord's Mark Industries Ltd. manufactures and sells AI-enabled hemodialysis machines (Lord's Renal Renalyx Machine), diagnostic self-test kits (LordsMed HIV 1&2 Self Test), and a 153-product US FDA-registered orthosurgical portfolio. The company also operates an Aureoon Dialysis-as-a-Service managed operations model that enables hospitals to run fully managed dialysis centres with zero capital investment, powered by the RenalOS AI clinical intelligence platform.

Product overview

Lord's Mark Industries operates as a diversified healthcare technology company with a platform-plus-modules architecture. The core offering centers on an integrated AI-powered renal care ecosystem comprising three interconnected components: the indigenous Lord's Renal Renalyx Machine (AI-enabled hemodialysis system), the RenalOS AI clinical intelligence platform (for monitoring and predictive analytics), and the Aureoon Dialysis-as-a-Service model (managed operations). This ecosystem is complemented by the LordsMed HIV 1&2 Self Test diagnostic product, a 153-product orthosurgical portfolio with US FDA registration, and an AI-powered breast cancer detection wearable device in development with CMET. The company positions itself at the intersection of medical devices, AI-powered healthcare technology, and indigenous manufacturing under the 'Make in India' initiative.

Differentiator

Problem solved

Functional benefit

Brands

• LordsMed: Diagnostic products brand including HIV 1&2 Self Test and other in-vitro diagnostic devices
• Lord's Renal Renalyx
• RenalOS
• Aureoon

Products and services

• Lord's Renal Renalyx Machine
• Aureoon Dialysis-as-a-Service
• LordsMed HIV 1&2 Self Test
• Orthosurgical Products Portfolio
• US FDA-Registered Healthcare Products Range

Quantifiable outcome

• Zero capital investment required from hospital partners for dialysis centre deployment
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Shakti Super Speciality HospitalflagshipOthers · 1 May 2026Shakti Super Speciality Hospital in Ahmedabad serves as the first deployment site for India's first fully integrated AI-powered renal care ecosystem. The hospital hosts the Lord's Renal Renalyx Machine, RenalOS AI clinical intelligence platform, and Aureoon Dialysis-as-a-Service model.
• Centre for Materials for Electronic Technology (CMET)coreStrategic or Co-development Partner · 1 March 2026Lord's Mark Industries Limited partnered with CMET to develop an AI-powered, radiation-free breast cancer detection wearable device. The device aims to improve early detection through advanced thermal sensors and AI analytics, with plans for global commercialization by the end of the year.
• Renalyx Health SystemscoreStrategic or Co-development Partner · 1 November 2025Lords Mark Industries Ltd. acquired an 85% stake in Renalyx Health Systems, a Bengaluru-based med-tech company specializing in AI-enabled hemodialysis systems. The acquisition strengthens Lords Mark's healthcare technology portfolio, increases access to advanced dialysis care, and supports indigenous medical innovation under the 'Make in India' initiative.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Regional players

• Trivitron Healthcare: Indian medical technology company manufacturing diagnostic instruments, IVD reagents, imaging equipment, and operating room devices. Closest Indian diversified medtech peer with overlapping IVD and device product lines.
• Transasia Bio-Medicals: Indian in-vitro diagnostics company with broad IVD reagents and instruments portfolio and strong domestic hospital channel. Comparable as an Indian IVD manufacturer with export ambitions overlapping LordsMed's diagnostic franchise.
• Poly Medicure: Indian medical devices company specializing in disposables and surgical consumables with growing international presence. Comparable as an Indian manufacturer scaling into regulated export markets like Lord's Mark's orthosurgical line.

Direct peers

• Nipro Corporation: Japanese medical device manufacturer with a sizeable dialysis business covering haemodialysis machines, dialyzers, and related consumables. Comparable product portfolio to Lord's Mark's Renalyx-based renal care offering.
• Fresenius Medical Care: Global leader in dialysis products and services, offering haemodialysis machines, dialyzers, and dialysis centre operations. Most directly comparable to Lord's Renal Renalyx Machine and Aureoon DaaS model in the same end market.
• DaVita: World's leading independent provider of kidney dialysis services and related lab services. Comparable to Lord's Mark on the dialysis-as-a-service and managed centre model, though DaVita is far larger and US-centric.
• B. Braun: German medical device and pharmaceutical company with a major haemodialysis equipment and services business through B. Braun Avitum. Directly competes in the same hospital dialysis equipment category as Renalyx machines.

Emerging players

• OraSure Technologies: US diagnostics company known for the OraQuick HIV self-test and other rapid point-of-care diagnostics. Most directly comparable peer in HIV self-testing, the same end market Lord's Mark targets through the LordsMed HIV 1&2 Self Test.

Broad incumbents

• Baxter International: Diversified medical products company with a legacy peritoneal dialysis franchise and broader medtech portfolio. Adjacent competitor in renal care plus comparable IVD and hospital products breadth relative to Lord's Mark's multi-line structure.
• Asahi Kasei Medical: Japanese manufacturer of dialysis membranes, therapeutic apheresis, and artificial kidneys. Comparable as an established supplier of core renal-care components consumed by dialysis programmes like the one Lord's Mark is building with Renalyx and Aureoon.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lord's Mark